id	sid	eid	entity	type
ajlm-804	1	1	daniel rhodes clinical affairs	ORG
ajlm-804	1	2	beckman coulter immunotech	PERSON
ajlm-804	1	3	marseille	ORG
ajlm-804	1	4	france	GPE
ajlm-804	1	5	publique hopitaux de paris	PERSON
ajlm-804	1	6	paris	GPE
ajlm-804	1	7	france	GPE
ajlm-804	1	8	mike keeney lawson	PERSON
ajlm-804	1	9	health research institute	ORG
ajlm-804	1	10	london health sciences centre	ORG
ajlm-804	1	11	st	GPE
ajlm-804	1	12	joseph	PERSON
ajlm-804	1	13	london	GPE
ajlm-804	1	14	ontario	GPE
ajlm-804	1	15	canada christophe parizot department	ORG
ajlm-804	1	16	university hospital	ORG
ajlm-804	1	17	paris	GPE
ajlm-804	1	18	france	GPE
ajlm-804	1	19	benjamins london health sciences centre	ORG
ajlm-804	1	20	london	GPE
ajlm-804	1	21	ontario	GPE
ajlm-804	1	22	canada	GPE
ajlm-804	1	23	lyon	ORG
ajlm-804	1	24	france	GPE
ajlm-804	1	25	jin zhang	PERSON
ajlm-804	1	26	beckman coulter	ORG
ajlm-804	1	27	miami	GPE
ajlm-804	1	28	florida	GPE
ajlm-804	1	29	united states	ORG
ajlm-804	1	30	justin rohrbach clinical affairs	ORG
ajlm-804	1	31	beckman coulter	ORG
ajlm-804	1	32	miami	GPE
ajlm-804	1	33	florida	GPE
ajlm-804	1	34	united states	GPE
ajlm-804	1	35	denise lawrie national health laboratory service	ORG
ajlm-804	1	36	charlotte	GPE
ajlm-804	1	37	johannesburg academic hospital	ORG
ajlm-804	1	38	johannesburg	GPE
ajlm-804	2	1	south africa	GPE
ajlm-804	2	2	deborah k. glencross	PERSON
ajlm-804	2	3	university of the witwatersrand	ORG
ajlm-804	2	4	johannesburg	GPE
ajlm-804	2	5	south africa	GPE
ajlm-804	2	6	national health laboratory services	ORG
ajlm-804	2	7	johannesburg	GPE
ajlm-804	2	8	south africa	GPE
ajlm-804	2	9	keeney m	PERSON
ajlm-804	2	10	cd4 lymphocyte panleucogating enumeration	ORG
ajlm-804	3	1	afr j	PERSON
ajlm-804	3	2	2019;8(1	CARDINAL
ajlm-804	3	3	cd4 lymphocyte panleucogating	ORG
ajlm-804	3	4	enumeration daniel rhodes	ORG
ajlm-804	3	5	guislaine carcelain	PERSON
ajlm-804	3	6	mike keeney	PERSON
ajlm-804	3	7	christophe parizot	PERSON
ajlm-804	3	8	dominika benjamins	PERSON
ajlm-804	3	9	jin zhang	PERSON
ajlm-804	3	10	justin rohrbach	PERSON
ajlm-804	3	11	denise lawrie	PERSON
ajlm-804	3	12	deborah k. glencross	PERSON
ajlm-804	3	13	13	CARDINAL
ajlm-804	3	14	mar. 2018	DATE
ajlm-804	3	15	18	CARDINAL
ajlm-804	3	16	mar. 2019	DATE
ajlm-804	3	17	05	CARDINAL
ajlm-804	3	18	dec.	DATE
ajlm-804	4	1	2019	DATE
ajlm-804	9	1	beckman coulter	PERSON
ajlm-804	9	2	plg	GPE
ajlm-804	10	1	plg	GPE
ajlm-804	11	1	between november 2014	DATE
ajlm-804	11	2	march 2015	DATE
ajlm-804	11	3	5	CARDINAL
ajlm-804	11	4	canada	GPE
ajlm-804	11	5	paris	GPE
ajlm-804	11	6	france	GPE
ajlm-804	11	7	lyon	ORG
ajlm-804	11	8	france	GPE
ajlm-804	11	9	the united states	GPE
ajlm-804	11	10	south africa	GPE
ajlm-804	12	1	two-hundred	CARDINAL
ajlm-804	12	2	plg	GPE
ajlm-804	13	1	155	CARDINAL
ajlm-804	14	1	440	CARDINAL
ajlm-804	14	2	over 5 days	DATE
ajlm-804	15	1	plg	ORG
ajlm-804	15	2	plg	GPE
ajlm-804	16	1	≤ 2.4%	PERCENT
ajlm-804	16	2	≤ 11.1%	PERCENT
ajlm-804	17	1	95%	PERCENT
ajlm-804	17	2	2.5th	LAW
ajlm-804	17	3	97.5th	CARDINAL
ajlm-804	17	4	453–1534	CARDINAL
ajlm-804	17	5	30.5%	PERCENT
ajlm-804	17	6	63.4%	PERCENT
ajlm-804	18	1	17.5 per hour	TIME
ajlm-804	18	2	122.5	CARDINAL
ajlm-804	18	3	8-hour	TIME
ajlm-804	18	4	one	CARDINAL
ajlm-804	19	1	plg	GPE
ajlm-804	21	1	4	CARDINAL
ajlm-804	22	1	cd4 lymphocyte enumeration and	ORG
ajlm-804	22	2	the last 25 years.4,5	DATE
ajlm-804	24	1	daily	DATE
ajlm-804	24	2	cd45	FAC
ajlm-804	24	3	cd4	ORG
ajlm-804	24	4	cd4	ORG
ajlm-804	25	1	plg cd4	GPE
ajlm-804	25	2	south african	NORP
ajlm-804	25	3	2004	DATE
ajlm-804	26	1	35	CARDINAL
ajlm-804	26	2	2007,12	CARDINAL
ajlm-804	26	3	60	CARDINAL
ajlm-804	26	4	201411	DATE
ajlm-804	26	5	beckman coulter	ORG
ajlm-804	26	6	beckman coulter, inc.	ORG
ajlm-804	26	7	miami	GPE
ajlm-804	26	8	florida	GPE
ajlm-804	26	9	united states	GPE
ajlm-804	26	10	beckman coulter, inc.	ORG
ajlm-804	26	11	miami	GPE
ajlm-804	26	12	florida	GPE
ajlm-804	26	13	united states	GPE
ajlm-804	26	14	beckman coulter, inc.	ORG
ajlm-804	26	15	miami	GPE
ajlm-804	26	16	florida	GPE
ajlm-804	26	17	united states	GPE
ajlm-804	26	18	cd45	LAW
ajlm-804	26	19	cd8 for cd4-positive	ORG
ajlm-804	27	1	2013-2014	DATE
ajlm-804	27	2	south african	NORP
ajlm-804	27	3	plg	GPE
ajlm-804	31	1	the national health laboratory service	ORG
ajlm-804	31	2	plg testing	ORG
ajlm-804	31	3	plg	GPE
ajlm-804	31	4	south african	NORP
ajlm-804	31	5	plg	GPE
ajlm-804	31	6	plg cd4	ORG
ajlm-804	31	7	south african	NORP
ajlm-804	32	1	plg	GPE
ajlm-804	32	2	intervals.20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42	CARDINAL
ajlm-804	34	1	south africa	GPE
ajlm-804	34	2	france	GPE
ajlm-804	34	3	lyon	ORG
ajlm-804	34	4	ac-2013-1808	ORG
ajlm-804	34	5	canada	GPE
ajlm-804	34	6	09763e	DATE
ajlm-804	34	7	the united states	GPE
ajlm-804	34	8	10259-05	CARDINAL
ajlm-804	35	1	france	GPE
ajlm-804	35	2	paris	GPE
ajlm-804	35	3	french	NORP
ajlm-804	35	4	loi jardé	PERSON
ajlm-804	35	5	2012-300	DATE
ajlm-804	37	1	cd4	ORG
ajlm-804	37	2	between november 2014	DATE
ajlm-804	37	3	march 2015	DATE
ajlm-804	37	4	four	CARDINAL
ajlm-804	37	5	canada	GPE
ajlm-804	37	6	paris	GPE
ajlm-804	37	7	france	GPE
ajlm-804	37	8	lyon	ORG
ajlm-804	37	9	france	GPE
ajlm-804	37	10	south africa	GPE
ajlm-804	38	1	270	CARDINAL
ajlm-804	38	2	2 months to 77 years	DATE
ajlm-804	39	1	thirty	CARDINAL
ajlm-804	39	2	22	CARDINAL
ajlm-804	39	3	8	CARDINAL
ajlm-804	39	4	cd4	ORG
ajlm-804	39	5	20	CARDINAL
ajlm-804	39	6	18	CARDINAL
ajlm-804	39	7	4	CARDINAL
ajlm-804	39	8	2	CARDINAL
ajlm-804	39	9	2	CARDINAL
ajlm-804	39	10	1	CARDINAL
ajlm-804	39	11	1	CARDINAL
ajlm-804	39	12	1	CARDINAL
ajlm-804	39	13	1	CARDINAL
ajlm-804	40	1	1	CARDINAL
ajlm-804	40	2	two	CARDINAL
ajlm-804	40	3	2	CARDINAL
ajlm-804	40	4	1	CARDINAL
ajlm-804	40	5	1	CARDINAL
ajlm-804	40	6	1	CARDINAL
ajlm-804	41	1	two hundred and forty	CARDINAL
ajlm-804	41	2	specimen ages	DATE
ajlm-804	41	3	20 to 71 hours	TIME
ajlm-804	42	1	between december 2014	DATE
ajlm-804	42	2	february 2015	DATE
ajlm-804	42	3	three	CARDINAL
ajlm-804	42	4	canada	GPE
ajlm-804	42	5	paris	GPE
ajlm-804	42	6	france	GPE
ajlm-804	42	7	the united states	GPE
ajlm-804	43	1	1	CARDINAL
ajlm-804	43	2	canada	GPE
ajlm-804	43	3	2	CARDINAL
ajlm-804	43	4	the etablissement francais du	ORG
ajlm-804	43	5	paris	GPE
ajlm-804	43	6	france	GPE
ajlm-804	43	7	3	CARDINAL
ajlm-804	43	8	beckman coulter	ORG
ajlm-804	43	9	miami	GPE
ajlm-804	43	10	florida	GPE
ajlm-804	43	11	united states	GPE
ajlm-804	44	1	cd4	ORG
ajlm-804	44	2	300	CARDINAL
ajlm-804	44	3	173	CARDINAL
ajlm-804	44	4	18–65 years	DATE
ajlm-804	45	1	eighteen	CARDINAL
ajlm-804	45	2	10	CARDINAL
ajlm-804	45	3	3	CARDINAL
ajlm-804	45	4	18 years of age	DATE
ajlm-804	45	5	2	CARDINAL
ajlm-804	45	6	1	CARDINAL
ajlm-804	45	7	1	CARDINAL
ajlm-804	45	8	cd4	ORG
ajlm-804	45	9	300	CARDINAL
ajlm-804	45	10	1	CARDINAL
ajlm-804	46	1	one hundred and fifty-five	CARDINAL
ajlm-804	46	2	24 hours	TIME
ajlm-804	47	1	one	CARDINAL
ajlm-804	47	2	south africa	GPE
ajlm-804	47	3	five days	DATE
ajlm-804	47	4	february 2015	DATE
ajlm-804	48	1	440	CARDINAL
ajlm-804	48	2	five days	DATE
ajlm-804	49	1	day	DATE
ajlm-804	49	2	cd4	ORG
ajlm-804	49	3	beckman coulter, inc.	ORG
ajlm-804	49	4	miami	GPE
ajlm-804	49	5	florida	GPE
ajlm-804	49	6	united states	GPE
ajlm-804	49	7	beckman coulter, inc.	ORG
ajlm-804	49	8	miami	GPE
ajlm-804	49	9	florida	GPE
ajlm-804	49	10	united states	GPE
ajlm-804	51	1	1	CARDINAL
ajlm-804	52	1	beckman coulter, inc.	ORG
ajlm-804	52	2	hialeah	ORG
ajlm-804	52	3	florida	GPE
ajlm-804	52	4	united states	GPE
ajlm-804	52	5	immunotech	ORG
ajlm-804	52	6	marseille	ORG
ajlm-804	52	7	france	GPE
ajlm-804	53	1	1	CARDINAL
ajlm-804	53	2	canada	GPE
ajlm-804	53	3	paris	GPE
ajlm-804	53	4	france	GPE
ajlm-804	53	5	lyon	ORG
ajlm-804	53	6	france	GPE
ajlm-804	53	7	south africa	GPE
ajlm-804	53	8	november 2014 to march 2015	DATE
ajlm-804	54	1	cd45	ORG
ajlm-804	54	2	cd45	LAW
ajlm-804	54	3	cd45	LAW
ajlm-804	56	1	aquios instrument cd4+	ORG
ajlm-804	56	2	plg	GPE
ajlm-804	58	1	plg cd4	GPE
ajlm-804	60	1	beckman coulter, inc.	ORG
ajlm-804	60	2	miami	GPE
ajlm-804	60	3	florida	GPE
ajlm-804	60	4	united states	GPE
ajlm-804	61	1	2	CARDINAL
ajlm-804	61	2	beckman coulter, inc.	ORG
ajlm-804	61	3	miami	GPE
ajlm-804	61	4	florida	GPE
ajlm-804	61	5	united states	GPE
ajlm-804	62	1	ep09-a2	PRODUCT
ajlm-804	62	2	comparison43	ORG
ajlm-804	63	1	1	CARDINAL
ajlm-804	63	2	2	CARDINAL
ajlm-804	63	3	1	CARDINAL
ajlm-804	64	1	cd4	ORG
ajlm-804	64	2	cd4	ORG
ajlm-804	65	1	plg	GPE
ajlm-804	65	2	plg	ORG
ajlm-804	65	3	50	CARDINAL
ajlm-804	65	4	100	CARDINAL
ajlm-804	65	5	200	CARDINAL
ajlm-804	65	6	350	CARDINAL
ajlm-804	65	7	500	CARDINAL
ajlm-804	67	1	two	CARDINAL
ajlm-804	69	1	as percent	PERCENT
ajlm-804	70	1	cd4	ORG
ajlm-804	70	2	201–1000	CARDINAL
ajlm-804	70	3	1000	CARDINAL
ajlm-804	70	4	351–1000	CARDINAL
ajlm-804	70	5	1000	CARDINAL
ajlm-804	70	6	200	CARDINAL
ajlm-804	70	7	350	CARDINAL
ajlm-804	70	8	1000	CARDINAL
ajlm-804	71	1	100	CARDINAL
ajlm-804	71	2	200	CARDINAL
ajlm-804	71	3	350	CARDINAL
ajlm-804	71	4	500	CARDINAL
ajlm-804	71	5	elsewhere46	ORG
ajlm-804	73	1	elsewhere47	ORG
ajlm-804	74	1	±	CARDINAL
ajlm-804	76	1	95%	PERCENT
ajlm-804	76	2	2.5th	LAW
ajlm-804	76	3	97.5th	CARDINAL
ajlm-804	77	1	whitney u	PERSON
ajlm-804	78	1	first	ORDINAL
ajlm-804	78	2	8-hour	TIME
ajlm-804	79	1	microsoft	ORG
ajlm-804	79	2	microsoft corporation	ORG
ajlm-804	79	3	redmond	GPE
ajlm-804	79	4	washington	GPE
ajlm-804	79	5	united states	GPE
ajlm-804	80	1	two hundred and forty	CARDINAL
ajlm-804	80	2	92	CARDINAL
ajlm-804	80	3	38.7%	PERCENT
ajlm-804	80	4	age 35.2 years	DATE
ajlm-804	80	5	146	CARDINAL
ajlm-804	80	6	61.3%	PERCENT
ajlm-804	80	7	age 42.6 years	DATE
ajlm-804	80	8	202	CARDINAL
ajlm-804	80	9	84.2%	PERCENT
ajlm-804	80	10	38	DATE
ajlm-804	80	11	15.8%	PERCENT
ajlm-804	81	1	cd4	PERSON
ajlm-804	81	2	339	CARDINAL
ajlm-804	81	3	22.65%	PERCENT
ajlm-804	81	4	359	CARDINAL
ajlm-804	81	5	23.47%	PERCENT
ajlm-804	81	6	0.05	CARDINAL
ajlm-804	81	7	361	CARDINAL
ajlm-804	81	8	22.20%	PERCENT
ajlm-804	81	9	948	CARDINAL
ajlm-804	81	10	32.28%	PERCENT
ajlm-804	81	11	0.001	CARDINAL
ajlm-804	82	1	cd4	ORG
ajlm-804	82	2	46–2645	CARDINAL
ajlm-804	83	1	0.992	CARDINAL
ajlm-804	83	2	plg	GPE
ajlm-804	83	3	2a	CARDINAL
ajlm-804	84	1	−7.8%	PERCENT
ajlm-804	85	1	12	CARDINAL
ajlm-804	85	2	1250	CARDINAL
ajlm-804	85	3	11	CARDINAL
ajlm-804	86	1	0.994	CARDINAL
ajlm-804	86	2	−0.16%	PERCENT
ajlm-804	86	3	2b	CARDINAL
ajlm-804	87	1	cd4	ORG
ajlm-804	87	2	0.992	CARDINAL
ajlm-804	87	3	2c	CARDINAL
ajlm-804	88	1	−6.8%	PERCENT
ajlm-804	89	1	2	CARDINAL
ajlm-804	89	2	panleucogating	ORG
ajlm-804	89	3	canada	GPE
ajlm-804	89	4	paris	GPE
ajlm-804	89	5	france	GPE
ajlm-804	89	6	lyon	ORG
ajlm-804	89	7	france	GPE
ajlm-804	89	8	south africa	GPE
ajlm-804	89	9	november 2014 to march 2015	DATE
ajlm-804	91	1	cd4	ORG
ajlm-804	91	2	200	CARDINAL
ajlm-804	91	3	350	CARDINAL
ajlm-804	92	1	−7.8%	PERCENT
ajlm-804	92	2	−8.1%	PERCENT
ajlm-804	92	3	−7.9%	PERCENT
ajlm-804	92	4	−8.1%	PERCENT
ajlm-804	92	5	1	CARDINAL
ajlm-804	93	1	1	CARDINAL
ajlm-804	93	2	cd4	ORG
ajlm-804	93	3	canada	GPE
ajlm-804	93	4	paris	GPE
ajlm-804	93	5	france	GPE
ajlm-804	93	6	lyon	ORG
ajlm-804	93	7	france	GPE
ajlm-804	93	8	south africa	GPE
ajlm-804	93	9	november 2014 to march 2015	DATE
ajlm-804	94	1	0.0 to 2.4%	PERCENT
ajlm-804	94	2	1.5 to 11.1%	PERCENT
ajlm-804	94	3	2	CARDINAL
ajlm-804	95	1	96.1%	PERCENT
ajlm-804	95	2	6.1%	PERCENT
ajlm-804	95	3	6.3%	PERCENT
ajlm-804	95	4	99.5%	PERCENT
ajlm-804	95	5	3.9%	PERCENT
ajlm-804	95	6	4.0%	PERCENT
ajlm-804	95	7	2	CARDINAL
ajlm-804	95	8	canada	GPE
ajlm-804	95	9	paris	GPE
ajlm-804	95	10	france	GPE
ajlm-804	95	11	lyon	ORG
ajlm-804	95	12	france	GPE
ajlm-804	95	13	south africa	GPE
ajlm-804	95	14	november 2014 to march 2015	DATE
ajlm-804	96	1	155	CARDINAL
ajlm-804	96	2	paris	GPE
ajlm-804	96	3	france	GPE
ajlm-804	96	4	0.73	CARDINAL
ajlm-804	96	5	canada	GPE
ajlm-804	96	6	0.59	CARDINAL
ajlm-804	96	7	united states	ORG
ajlm-804	96	8	0.39	CARDINAL
ajlm-804	97	1	40 years	DATE
ajlm-804	97	2	canada	GPE
ajlm-804	97	3	45 years	DATE
ajlm-804	97	4	united states	GPE
ajlm-804	97	5	36	CARDINAL
ajlm-804	97	6	45 years	DATE
ajlm-804	97	7	canada	GPE
ajlm-804	97	8	52	CARDINAL
ajlm-804	97	9	41 years	DATE
ajlm-804	97	10	united states	GPE
ajlm-804	98	1	paris	GPE
ajlm-804	98	2	france	GPE
ajlm-804	99	1	±	CARDINAL
ajlm-804	99	2	canada	GPE
ajlm-804	99	3	1009	CARDINAL
ajlm-804	99	4	239	CARDINAL
ajlm-804	99	5	the united states	GPE
ajlm-804	99	6	866 ±	CARDINAL
ajlm-804	99	7	paris	GPE
ajlm-804	99	8	france	GPE
ajlm-804	99	9	802 ± 273	CARDINAL
ajlm-804	101	1	95%	PERCENT
ajlm-804	102	1	0.61	CARDINAL
ajlm-804	102	2	0.48	CARDINAL
ajlm-804	102	3	3	CARDINAL
ajlm-804	103	1	±	CARDINAL
ajlm-804	103	2	888 ±	CARDINAL
ajlm-804	103	3	±	CARDINAL
ajlm-804	103	4	46.82 ± 7.86%	MONEY
ajlm-804	104	1	95%	PERCENT
ajlm-804	104	2	2.5th	LAW
ajlm-804	104	3	97.5th	CARDINAL
ajlm-804	104	4	453–1534	CARDINAL
ajlm-804	104	5	30.5%	PERCENT
ajlm-804	104	6	63.4%	PERCENT
ajlm-804	104	7	4	CARDINAL
ajlm-804	105	1	5	CARDINAL
ajlm-804	106	1	3	CARDINAL
ajlm-804	106	2	canada	GPE
ajlm-804	106	3	paris	GPE
ajlm-804	106	4	france	GPE
ajlm-804	106	5	united states	GPE
ajlm-804	106	6	december 2014 to february 2015	DATE
ajlm-804	107	1	4	CARDINAL
ajlm-804	107	2	95%	PERCENT
ajlm-804	107	3	2.5th	LAW
ajlm-804	107	4	97.5th	CARDINAL
ajlm-804	107	5	canada	GPE
ajlm-804	107	6	paris	GPE
ajlm-804	107	7	france	GPE
ajlm-804	107	8	united states	GPE
ajlm-804	107	9	december 2014 to february 2015	DATE
ajlm-804	108	1	5	CARDINAL
ajlm-804	108	2	2.5th	LAW
ajlm-804	108	3	97.5th	CARDINAL
ajlm-804	108	4	canada	GPE
ajlm-804	108	5	paris	GPE
ajlm-804	108	6	france	GPE
ajlm-804	108	7	lyon	ORG
ajlm-804	108	8	france	GPE
ajlm-804	108	9	south africa	GPE
ajlm-804	108	10	november 2014 to march 2015	DATE
ajlm-804	109	1	plg	GPE
ajlm-804	109	2	six	CARDINAL
ajlm-804	109	3	paris	GPE
ajlm-804	110	1	300–500	CARDINAL
ajlm-804	111	1	500	CARDINAL
ajlm-804	112	1	french	NORP
ajlm-804	112	2	cd4	ORG
ajlm-804	112	3	500	CARDINAL
ajlm-804	113	1	300	CARDINAL
ajlm-804	113	2	1	CARDINAL
ajlm-804	113	3	french	NORP
ajlm-804	113	4	the etablissement francais du	ORG
ajlm-804	113	5	2	CARDINAL
ajlm-804	113	6	300	CARDINAL
ajlm-804	113	7	532	CARDINAL
ajlm-804	113	8	453	CARDINAL
ajlm-804	115	1	440	CARDINAL
ajlm-804	115	2	5 days	DATE
ajlm-804	115	3	6	CARDINAL
ajlm-804	116	1	first	ORDINAL
ajlm-804	116	2	39.2 minutes	TIME
ajlm-804	117	1	17.5	CARDINAL
ajlm-804	117	2	122.5	CARDINAL
ajlm-804	117	3	8-hour	TIME
ajlm-804	117	4	minus 1 hour	TIME
ajlm-804	118	1	one hour	TIME
ajlm-804	119	1	6	CARDINAL
ajlm-804	119	2	south africa	GPE
ajlm-804	119	3	february 2015	DATE
ajlm-804	120	1	plg	GPE
ajlm-804	120	2	plg cd4	ORG
ajlm-804	121	1	cd4	ORG
ajlm-804	121	2	plg	GPE
ajlm-804	122	1	plg	GPE
ajlm-804	122	2	plg	ORG
ajlm-804	122	3	−7.8%	ORG
ajlm-804	123	1	−6.8%	PERCENT
ajlm-804	124	1	cd45	ORG
ajlm-804	124	2	cd4	ORG
ajlm-804	124	3	plg	GPE
ajlm-804	124	4	cd45	PRODUCT
ajlm-804	124	5	cd4/ss	ORG
ajlm-804	124	6	10	CARDINAL
ajlm-804	124	7	0.996	CARDINAL
ajlm-804	125	1	around 8% – 11%	PERCENT
ajlm-804	125	2	1000	CARDINAL
ajlm-804	128	1	plg	GPE
ajlm-804	128	2	≤ 2.4%	PERCENT
ajlm-804	128	3	≤ 11.1%	PERCENT
ajlm-804	129	1	95%	PERCENT
ajlm-804	129	2	2.5th	LAW
ajlm-804	129	3	97.5th	CARDINAL
ajlm-804	129	4	5	CARDINAL
ajlm-804	132	1	intake.21,22,27,28,29,33,36,38,39,42,49,54	ORG
ajlm-804	133	1	north america	LOC
ajlm-804	133	2	cd4	ORG
ajlm-804	133	3	plg	ORG
ajlm-804	136	1	plg cd4 method12,16	GPE
ajlm-804	136	2	south african	NORP
ajlm-804	136	3	technology8	GPE
ajlm-804	137	1	up to 100	CARDINAL
ajlm-804	138	1	12	CARDINAL
ajlm-804	138	2	96	CARDINAL
ajlm-804	138	3	6 hours	TIME
ajlm-804	138	4	plg daily	ORG
ajlm-804	142	1	the past 30 years	DATE
ajlm-804	142	2	cd4	ORG
ajlm-804	142	3	progress3	PERSON
ajlm-804	142	4	cd4	ORG
ajlm-804	142	5	cd4	ORG
ajlm-804	142	6	care64	PERSON
ajlm-804	142	7	cd4	ORG
ajlm-804	143	1	african	NORP
ajlm-804	144	1	plg	GPE
ajlm-804	147	1	paris	GPE
ajlm-804	147	2	france	GPE
ajlm-804	147	3	virginie merere	PERSON
ajlm-804	147	4	lyon	ORG
ajlm-804	147	5	france	GPE
ajlm-804	147	6	sophie	PERSON
ajlm-804	147	7	karin dumoulin	PERSON
ajlm-804	147	8	audrey milhau	PERSON
ajlm-804	147	9	laura dinier	PERSON
ajlm-804	147	10	united states	GPE
ajlm-804	147	11	south africa	GPE
ajlm-804	147	12	keshendree moodley	ORG
ajlm-804	148	1	canada	GPE
ajlm-804	148	2	dominika benjamins	PERSON
ajlm-804	149	1	karen lo	PERSON
ajlm-804	149	2	robert magari	PERSON
ajlm-804	151	1	south african	NORP
ajlm-804	151	2	1 405 073	QUANTITY
ajlm-804	151	3	7 670	CARDINAL
ajlm-804	151	4	793	CARDINAL
ajlm-804	151	5	the plg/cd4	ORG
ajlm-804	151	6	cd4	ORG
ajlm-804	152	1	the national health laboratory service	ORG
ajlm-804	152	2	beckman coulter	PERSON
ajlm-804	153	1	m.k.	GPE
ajlm-804	153	2	beckman coulter	PERSON
ajlm-804	154	1	d.r.	GPE
ajlm-804	154	2	j.r.	GPE
ajlm-804	154	3	j.z.	GPE
ajlm-804	154	4	beckman coulter	ORG
ajlm-804	157	1	beckman coulter, inc.	ORG
ajlm-804	158	1	miami	GPE
ajlm-804	158	2	florida	GPE
ajlm-804	158	3	united states	GPE
ajlm-804	161	1	lesar wj	PERSON
ajlm-804	162	1	cd4+ lymphocyte	ORG
ajlm-804	163	1	j clin	PERSON
ajlm-804	164	1	1989;92(2):206–209	CARDINAL
ajlm-804	165	1	https://doi.org/10.1093/ajcp/92.2.206 pedersen c	ORG
ajlm-804	165	2	gerstoft j	PERSON
ajlm-804	165	3	danish	NORP
ajlm-804	165	4	1981	DATE
ajlm-804	165	5	1989	DATE
ajlm-804	168	1	lee	PERSON
ajlm-804	168	2	phillips	PERSON
ajlm-804	168	3	janossy g	PERSON
ajlm-804	168	4	griffiths p	PERSON
ajlm-804	168	5	11 years	DATE
ajlm-804	170	1	1991;303(6810):1093–1096	CARDINAL
ajlm-804	171	1	mandy f	PERSON
ajlm-804	171	2	janossy g	PERSON
ajlm-804	171	3	bergeron m	ORG
ajlm-804	171	4	pilon r	PERSON
ajlm-804	171	5	faucher s. affordable cd4	PERSON
ajlm-804	171	6	2008	DATE
ajlm-804	172	1	cytom	GPE
ajlm-804	173	1	2008;74	CARDINAL
ajlm-804	173	2	1	CARDINAL
ajlm-804	174	1	nicholson j	PERSON
ajlm-804	174	2	autran b	PERSON
ajlm-804	174	3	janossy g. t	PERSON
ajlm-804	174	4	20-year	DATE
ajlm-804	176	1	2002;50(2):39–45	CARDINAL
ajlm-804	177	1	janossy g	PERSON
ajlm-804	177	2	jani	PERSON
ajlm-804	177	3	gohde w.	PERSON
ajlm-804	179	1	2000;111(4):1198–1208	CARDINAL
ajlm-804	179	2	sherman gg	PERSON
ajlm-804	179	3	patel jm	PERSON
ajlm-804	179	4	mendelow bv	PERSON
ajlm-804	179	5	glencross dk.	PERSON
ajlm-804	180	1	cd4+	PERSON
ajlm-804	182	1	janossy g	PERSON
ajlm-804	182	2	jani iv	PERSON
ajlm-804	182	3	bradley nj	PERSON
ajlm-804	182	4	bikoue	ORG
ajlm-804	183	1	cd45	LAW
ajlm-804	184	1	clin diagn	PERSON
ajlm-804	185	1	2002;9(5):1085–1094	DATE
ajlm-804	187	1	pima	GPE
ajlm-804	187	2	cd4	ORG
ajlm-804	188	1	2011	DATE
ajlm-804	188	2	5th	ORDINAL
ajlm-804	188	3	durban	ORG
ajlm-804	189	1	jani iv	PERSON
ajlm-804	191	1	2011;25(6):807–812	CARDINAL
ajlm-804	192	1	plos one	PERSON
ajlm-804	193	1	2014;9(12):e114727	CARDINAL
ajlm-804	194	1	https://doi.org/10.1371/journal.pone.0114727 glencross dk	PERSON
ajlm-804	194	2	janossy g	PERSON
ajlm-804	195	1	south african	NORP
ajlm-804	196	1	cytom	GPE
ajlm-804	197	1	2008;74	CARDINAL
ajlm-804	197	2	1	CARDINAL
ajlm-804	198	1	mendelow bv	PERSON
ajlm-804	198	2	stevens ws	PERSON
ajlm-804	199	1	2003;93(4):262–263	CARDINAL
ajlm-804	199	2	glencross dk	PERSON
ajlm-804	199	3	stevens ws	PERSON
ajlm-804	199	4	mandy f. african	PERSON
ajlm-804	201	1	cytometry b clin	ORG
ajlm-804	201	2	cytom	GPE
ajlm-804	202	1	2008;74	CARDINAL
ajlm-804	202	2	1	CARDINAL
ajlm-804	203	1	pattanapanyasat k	PERSON
ajlm-804	203	2	noulsri e	ORG
ajlm-804	204	1	thailand	GPE
ajlm-804	205	1	cytom	GPE
ajlm-804	206	1	2005;65(1):29–36	ORDINAL
ajlm-804	207	1	https://doi.org/10.1002/cyto.b.20052 glencross dk	PERSON
ajlm-804	207	2	scott le	PERSON
ajlm-804	207	3	jani iv	PERSON
ajlm-804	207	4	barnett	PERSON
ajlm-804	207	5	janossy g. cd45	PERSON
ajlm-804	209	1	2002;50(2):69–77	CARDINAL
ajlm-804	210	1	denny tn	PERSON
ajlm-804	210	2	bergeron m	ORG
ajlm-804	211	1	north american	NORP
ajlm-804	211	2	cd4	ORG
ajlm-804	211	3	plg	GPE
ajlm-804	212	1	cytometry b clin	ORG
ajlm-804	212	2	cytom	GPE
ajlm-804	213	1	2008;74	CARDINAL
ajlm-804	213	2	1	CARDINAL
ajlm-804	214	1	https://doi.org/10.1002/cyto.b.20417 cassim n	PERSON
ajlm-804	214	2	schnippel k	PERSON
ajlm-804	214	3	south africa	GPE
ajlm-804	215	1	plos one	PERSON
ajlm-804	216	1	2014;9(12):e115420	CARDINAL
ajlm-804	217	1	south africa	GPE
ajlm-804	219	1	https://doi.org/10.7196/samj.2016.v106i1.10081 beckman coulter	PERSON
ajlm-804	222	1	april 2015;pp	TIME
ajlm-804	223	1	6-1 to 6-1	DATE
ajlm-804	223	2	15	CARDINAL
ajlm-804	223	3	dec 2018	DATE
ajlm-804	224	1	ullrich k	PERSON
ajlm-804	224	2	franke a. lymphocyte	PERSON
ajlm-804	224	3	100	CARDINAL
ajlm-804	224	4	german	NORP
ajlm-804	225	1	clin immunol	PERSON
ajlm-804	226	1	2005;116(2):192–197	PERSON
ajlm-804	228	1	italian	NORP
ajlm-804	229	1	haematologica	PERSON
ajlm-804	230	1	1999;84(6):499–504	CARDINAL
ajlm-804	230	2	moreno-galvan m	ORG
ajlm-804	230	3	palafox a. cd4+ cd8+	PERSON
ajlm-804	230	4	mexico city	GPE
ajlm-804	231	1	clin	PERSON
ajlm-804	232	1	2013;20(2):306–308	CARDINAL
ajlm-804	234	1	stevens w	PERSON
ajlm-804	234	2	glencross dk	PERSON
ajlm-804	235	1	cd4 lymphocyte count	ORG
ajlm-804	237	1	bussmann h	ORG
ajlm-804	237	2	wester cw	ORG
ajlm-804	237	3	masupu kv	PERSON
ajlm-804	237	4	botswana	GPE
ajlm-804	238	1	clin diagn	PERSON
ajlm-804	239	1	2004;11(5):930–935	CARDINAL
ajlm-804	240	1	ambrose lr	PERSON
ajlm-804	240	2	longwe	PERSON
ajlm-804	240	3	french	NORP
ajlm-804	240	4	two	CARDINAL
ajlm-804	242	1	mfinanga sg	PERSON
ajlm-804	242	2	bruun jn	PERSON
ajlm-804	242	3	tanzania	GPE
ajlm-804	243	1	bmc infect dis	ORG
ajlm-804	244	1	2009;9:1	CARDINAL
ajlm-804	245	1	schneider p	PERSON
ajlm-804	245	2	kleinfeldt	PERSON
ajlm-804	245	3	southern tanzania	LOC
ajlm-804	247	1	2008;13(5):612–625	CARDINAL
ajlm-804	248	1	mbena	PERSON
ajlm-804	248	2	gaines h	ORG
ajlm-804	248	3	biberfeld g. lymphocyte	PERSON
ajlm-804	248	4	dar es salaam	GPE
ajlm-804	248	5	tanzania	GPE
ajlm-804	248	6	two	CARDINAL
ajlm-804	250	1	2003;277(1–2):65–74	CARDINAL
ajlm-804	251	1	nyamache ak	ORG
ajlm-804	251	2	gicheru mm	PERSON
ajlm-804	251	3	khamadi sa	PERSON
ajlm-804	251	4	lihana rw	PERSON
ajlm-804	251	5	okoth v.	PERSON
ajlm-804	251	6	cd8 lymphocyte	ORG
ajlm-804	251	7	kenyans	NORP
ajlm-804	254	1	kibaya rs	PERSON
ajlm-804	254	2	bautista ct	PERSON
ajlm-804	254	3	kericho	GPE
ajlm-804	254	4	kenya	GPE
ajlm-804	255	1	plos one	PERSON
ajlm-804	256	1	2008;3(10):e3327	CARDINAL
ajlm-804	257	1	eastern	ORG
ajlm-804	257	2	southern africa	GPE
ajlm-804	258	1	plos one	PERSON
ajlm-804	259	1	2009;4(2):e4401	CARDINAL
ajlm-804	260	1	waako p	PERSON
ajlm-804	261	1	uganda	GPE
ajlm-804	264	1	gedefaw l.	PERSON
ajlm-804	264	2	cd8(+	PERSON
ajlm-804	264	3	cd8(+	ORG
ajlm-804	264	4	university of gondar hospital	ORG
ajlm-804	264	5	north west	GPE
ajlm-804	264	6	ethiopia	GPE
ajlm-804	266	1	2014;2014:267450	CARDINAL
ajlm-804	267	1	https://doi.org/10.1155/2014/267450	ORG
ajlm-804	267	2	tilahun t	GPE
ajlm-804	268	1	immunohematological	PERSON
ajlm-804	268	2	ethiopians	NORP
ajlm-804	269	1	clin	PERSON
ajlm-804	270	1	dk	PERSON
ajlm-804	270	2	cd4	ORG
ajlm-804	270	3	cd8 lymphocyte	PRODUCT
ajlm-804	270	4	nigerian	NORP
ajlm-804	271	1	clin vaccine immunol	PERSON
ajlm-804	273	1	klose n	PERSON
ajlm-804	274	1	immunohematological	PERSON
ajlm-804	274	2	burkina	GPE
ajlm-804	274	3	faso	GPE
ajlm-804	275	1	clin vaccine immunol	ORG
ajlm-804	276	1	2007;14(6):782–784	CARDINAL
ajlm-804	277	1	balakrishnan p	PERSON
ajlm-804	277	2	mohanakrishnan j	PERSON
ajlm-804	278	1	chennai	GPE
ajlm-804	278	2	india	GPE
ajlm-804	279	1	indian	NORP
ajlm-804	280	1	2009;129(1):59–63	DATE
ajlm-804	280	2	uppal ss	PERSON
ajlm-804	280	3	dhot ps	PERSON
ajlm-804	280	4	cd4	ORG
ajlm-804	280	5	cd8 lymphocyte	PRODUCT
ajlm-804	280	6	indian	NORP
ajlm-804	282	1	2003;52(1):32–36	CARDINAL
ajlm-804	282	2	chng wj	PERSON
ajlm-804	282	3	tan gb	PERSON
ajlm-804	282	4	kuperan p.	PERSON
ajlm-804	282	5	asian	NORP
ajlm-804	283	1	clin diagn	ORG
ajlm-804	284	1	2004;11(1):168–173	CARDINAL
ajlm-804	285	1	wong ws	PERSON
ajlm-804	285	2	hong kong	GPE
ajlm-804	285	3	chinese	NORP
ajlm-804	286	1	clin vaccine immunol	ORG
ajlm-804	287	1	2013;20(4):602–606	CARDINAL
ajlm-804	288	1	jiang w	PERSON
ajlm-804	288	2	kang l	PERSON
ajlm-804	289	1	cd4	ORG
ajlm-804	289	2	cd8 lymphocyte	PRODUCT
ajlm-804	289	3	chinese	NORP
ajlm-804	289	4	shanghai	GPE
ajlm-804	290	1	clin	GPE
ajlm-804	291	1	2004;11(4):811–813	CARDINAL
ajlm-804	293	1	2nd	ORDINAL
ajlm-804	293	2	clsi	PERSON
ajlm-804	293	3	ep09-a2	PRODUCT
ajlm-804	294	1	wayne	PERSON
ajlm-804	294	2	2002	DATE
ajlm-804	297	1	3rd	ORDINAL
ajlm-804	298	1	clsi guideline	PERSON
ajlm-804	299	1	wayne	PERSON
ajlm-804	299	2	2010	DATE
ajlm-804	300	1	jm	ORG
ajlm-804	300	2	altman	PERSON
ajlm-804	301	1	two	CARDINAL
ajlm-804	302	1	lancet	ORG
ajlm-804	303	1	1986;327(8476):307–310	ORDINAL
ajlm-804	304	1	https://doi.org/10.1016/s0140-6736(86)90837-8 bwana p	PERSON
ajlm-804	304	2	vojnov l	ORG
ajlm-804	305	1	the bd facs presto	ORG
ajlm-804	305	2	cd4	ORG
ajlm-804	306	1	plos	PERSON
ajlm-804	306	2	one	CARDINAL
ajlm-804	307	1	2015;10(12):e0145586	CARDINAL
ajlm-804	308	1	scott le	PERSON
ajlm-804	308	2	glencross dk	PERSON
ajlm-804	309	1	cytom	GPE
ajlm-804	310	1	2003;54b(1):46–53	ORG
ajlm-804	311	1	glencross dk	PERSON
ajlm-804	311	2	south africa	GPE
ajlm-804	312	1	plos one.	ORG
ajlm-804	313	1	2017;12(11):e0187456	CARDINAL
ajlm-804	314	1	wm	PERSON
ajlm-804	314	2	de groot	PERSON
ajlm-804	314	3	van den beemd	PERSON
ajlm-804	318	1	1997;130(3):388–393	CARDINAL
ajlm-804	318	2	sollis ka	PERSON
ajlm-804	318	3	glover s	PERSON
ajlm-804	320	1	plos one	PERSON
ajlm-804	321	1	2015;10(3):e0115019	CARDINAL
ajlm-804	322	1	stevens w	PERSON
ajlm-804	322	2	scott le	PERSON
ajlm-804	322	3	crowe sm	PERSON
ajlm-804	322	4	spira t.	PERSON
ajlm-804	323	1	nat rev microbiol	PERSON
ajlm-804	324	1	2008;6	CARDINAL
ajlm-804	325	1	https://doi.org/10.1038/nrmicro2000	NORP
ajlm-804	327	1	geneva	GPE
ajlm-804	327	2	switzerland	GPE
ajlm-804	327	3	2016	DATE
ajlm-804	328	1	mandala wl	PERSON
ajlm-804	328	2	control lymphocyte	ORG
ajlm-804	328	3	one	CARDINAL
ajlm-804	329	1	clin immunol	PERSON
ajlm-804	330	1	2014;134(3):759–761.e8	CARDINAL
ajlm-804	331	1	maini mk	PERSON
ajlm-804	331	2	gilson rj	PERSON
ajlm-804	332	1	genitourin med	PERSON
ajlm-804	333	1	1996;72(1):27–31	CARDINAL
ajlm-804	333	2	https://doi.org/10.1136/sti.72.1.27 glencross dk	PERSON
ajlm-804	333	3	stevens g	PERSON
ajlm-804	333	4	scott le	PERSON
ajlm-804	333	5	mendelow bv	PERSON
ajlm-804	333	6	stevens w.	PERSON
ajlm-804	334	1	j. 2002;92(4):248	PRODUCT
ajlm-804	335	1	scott le	PERSON
ajlm-804	335	2	glencross dk	PERSON
ajlm-804	336	1	cytom.	DATE
ajlm-804	339	1	denny t	PERSON
ajlm-804	339	2	bergeron m	ORG
ajlm-804	340	1	cd4	ORG
ajlm-804	340	2	plg	GPE
ajlm-804	342	1	boston	GPE
ajlm-804	342	2	ma	GPE
ajlm-804	342	3	2005	DATE
ajlm-804	343	1	zhang j	PERSON
ajlm-804	343	2	quessada v	PERSON
ajlm-804	343	3	de castro j.	PERSON
ajlm-804	343	4	96	CARDINAL
ajlm-804	344	1	african	NORP
ajlm-804	345	1	cape town	GPE
ajlm-804	345	2	south africa	GPE
ajlm-804	345	3	2016	DATE
ajlm-804	346	1	world health organization	ORG
ajlm-804	347	1	3	CARDINAL
ajlm-804	347	2	5	CARDINAL
ajlm-804	349	1	zambia	GPE
ajlm-804	349	2	2003 nov 18–21	DATE
ajlm-804	350	1	2018	DATE
ajlm-804	350	2	dec 15	DATE
ajlm-804	351	1	ford	PERSON
ajlm-804	351	2	pozniak	PERSON
ajlm-804	353	1	lancet	ORG
ajlm-804	354	1	2015;15(2):241–247	CARDINAL
ajlm-804	355	1	bor j	ORG
ajlm-804	355	2	nattey	PERSON
ajlm-804	356	1	south africa’s	GPE
ajlm-804	357	1	clin inf dis	ORG
ajlm-804	358	1	2018;66	CARDINAL
ajlm-804	358	2	2	CARDINAL
ajlm-804	358	3	s111	ORG
ajlm-804	359	1	cd4	ORG
ajlm-804	359	2	100	CARDINAL
ajlm-804	360	1	52	CARDINAL
ajlm-804	361	1	j. 2017;107(6):507–513	PERSON
ajlm-804	362	1	july 2017	DATE
ajlm-804	364	1	geneva	GPE
ajlm-804	364	2	2017	CARDINAL
ajlm-804	365	1	2018	DATE
ajlm-804	365	2	dec 15	DATE
ajlm-804	368	1	pretoria	GPE
ajlm-804	368	2	south africa	GPE
ajlm-804	368	3	department of health, republic of south africa	ORG
ajlm-804	368	4	2015	DATE
ajlm-804	368	5	2018	DATE
ajlm-804	368	6	dec 15	DATE
ajlm-804	369	1	ford	PERSON
ajlm-804	369	2	vitoria m	PERSON
ajlm-804	369	3	greene g	PERSON
ajlm-804	370	1	curr opin	PERSON
ajlm-804	371	1	2017;12(2):123–128	CARDINAL
ajlm-804	371	2	venter f.	PERSON
ajlm-804	374	1	2016;17(1):446	CARDINAL